(Q53390272)
Statements
Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma (English)
Thomas E Witzig
Myron S Czuczman
Christos Emmanouilides
Robin Joyce
Brad L Pohlman
Gregory A Wiseman
Norman Padre
Antonio J Grillo-López
Pratik Multani
Christine A White